Dr. Reddy's Laboratories Income Statement Analysis

Revenue, earnings, and profit margins in billions INR

Scroll to see more
Dr. Reddy's Laboratories Limited income statement - Annual data in billions INR
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Revenue & Gross Profit
Revenue325.54279.162.99214.39189.72174.60153.85
Cost of Revenue135.11115.56106.54100.5586.6580.5970.42
Gross Profit190.43163.61139.34113.84103.0894.0183.43
Operating Expenses
Research & Development27.3822.870.2417.4816.5415.4115.61
Selling, General & Administrative93.8777.200.8563.0454.6550.1348.68
Operating Expenses118.59100.071.0880.5270.2161.2463.60
Operating Income71.8463.530.6233.3232.8732.7719.83
Other Income/Expense
Interest Income2.682.281.180.972.620.890.77
Interest Expense2.83-1.71-1.430.960.970.980.89
Other Income/Expense4.94-7.50-67.52-2.76-8.11-14.652.73
Income
Income Before Tax76.7871.870.6631.6026.4118.0322.44
Income Tax Expense19.5416.1915.308.739.18-1.473.65
Net Income56.5455.6845.0722.8717.2419.5018.80
Net Income - Continuous Operations56.5455.6845.0723.570.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA96.6788.4274.4342.4640.1831.4935.52
EBIT79.6173.5861.8030.6427.3819.0223.33
Depreciation & Amortization17.0613.70-12.64-11.8212.800.000.00
Earnings Per Share
Basic EPS68.00334.003.00142.00104.00118.00113.00
Diluted EPS68.00334.003.00142.00104.00117.00113.00
Basic Shares Outstanding0.830.170.170.170.170.170.17
Diluted Shares Outstanding0.830.170.170.170.170.170.17